Boehringer Ingelheim Venture Fund Investor

Boehringer Ingelheim Venture Fund intends to invest in groundbreaking therapeutic approaches and technologies.
Technology: DeepTech
Industry: Longevity Industry 2022
Headquarters: Ingelheim Am Rhein, Rheinland-Pfalz, Germany
Zip: NA
Founded Date: 2010-01-01
Employees Number: 11-50
Investor Type: Corporate Venture Capital
Investment Stage: Early Stage Venture, Seed
Number Of Exits: 8
Acquisitions Number: 8
Investors Number: NA
Estimated Revenue: $1M to $10M

Visit Website
info@earlydx.com
Register and Claim Ownership